유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - azacitidine - leikēmija, mieloīds, akūts - antineoplastiski līdzekļi - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).

유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastiski līdzekļi - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastiski līdzekļi - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

라트비아 - 라트비아어 - Pārtikas un veterinārais dienests, Zemkopības ministrija

ražots polijā pēc sia jonnex - farma, stabu iela 47/2, rīga, lv - 1011, latvija pasūtījuma - cits, apvalkota tablete

라트비아 - 라트비아어 - Pārtikas un veterinārais dienests, Zemkopības ministrija

tablete

라트비아 - 라트비아어 - Pārtikas un veterinārais dienests, Zemkopības ministrija

elit-pharm, sia - tablete

유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

celgene europe ltd. - romidepsin - limfoma, ne-hodžkina - antineoplastiski līdzekļi - attieksmes perifērās t-šūnu limfomas (ptcl),.

유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - pomalidomide - multiple mieloma - imūnsupresanti - imnovid kopā ar bortezomib un deksametazona ir norādīts ārstēšanai pieaugušiem pacientiem ar multiplā mieloma, kuri ir saņēmuši vismaz vienu pirms ārstēšanas shēmu, tostarp lenalidomide. imnovid kombinācijā ar deksametazons norāda attieksmi pret pieaugušiem pacientiem ar atkal un ugunsizturīgu vairāku mielomu, kuri ir saņēmuši vismaz divas iepriekšējas dziedniecības režīmus, tajā skaitā gan lenalidomide, gan bortezomib, un apliecināja slimības progresēšanu, par pēdējo terapija.

라트비아 - 라트비아어 - Pārtikas un veterinārais dienests, Zemkopības ministrija

vitar, s.r.o. - cits, košļājama tablete

라트비아 - 라트비아어 - Pārtikas un veterinārais dienests, Zemkopības ministrija

alina farma, sia - tablete